United States

Idera Pharmaceuticals Inc (IDRA.OQ)

IDRA.OQ on NASDAQ Stock Exchange Capital Market

30 Sep 2016
Change (% chg)

$0.25 (+10.82%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Tue, Sep 27 2016

BRIEF-Idera Pharmaceuticals announced new pre-clinical data on mechanism of action supporting selective targeting of single point mutations

* Based on specificity in targeting RNA data indicates that 3GA could be used to treat diseases that require allele-specificity

BRIEF-Idera Pharmaceuticals reports data from phase 1 trial of Intra-tumoral IMO-2125

* Idera Pharmaceuticals reports promising data from ongoing phase 1 dose escalation in clinical trial of intra-tumoral IMO-2125 in combination with Ipilimumab in patients with PD-1 refractory metastatic melanoma

BRIEF-Idera Pharmaceuticals Q2 loss per share $0.11

* Idera Pharmaceuticals reports second quarter 2016 financial results and provides corporate update

BRIEF-Idera Pharmaceuticals reports Q1 loss per share $0.11

* Idera pharmaceuticals reports first quarter 2016 financial results and provides corporate update

Select another date: